Kallikrein 5 is a member of the kallikrein family of extracellular proteases that includes the prostate-specific antigen, and it is currently emerging as some of the most prominent biomarkers of tumor progression for various types of cancers [53], [54], [55]. This evidence concerns the gene KLK3 and neoplasm.